vTv Therapeutics: Q1 Earnings Insights

vTv Therapeutics VTVT reported its Q1 earnings results on Thursday, May 12, 2022 at 07:45 AM.

Here's what investors need to know about the announcement.

vTv Therapeutics missed estimated earnings by 25.0%, reporting an EPS of $-0.1 versus an estimate of $-0.08.

Revenue was up $1.01 million from the same period last year.

Last quarter the company missed on EPS by $0.04 which was followed by a 0.37% increase in the share price the next day.

Here's a look at vTv Therapeutics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.07	-0.06	-0.07	-0.06
EPS Actual	-0.11	-0.02	-0.01	-0.09
Revenue Estimate	1.00M	2.80M	1.00M	987.00K
Revenue Actual	9.00K	3.00M	9.00K	987.00K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for vTv Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar